Equity · Healthcare
ACH
NYSEAccendra Health Inc/va/ (ACH)
The line runs 1.39 USD on 10 August through 0.2031 USD on 6 November, on a scale from 0.0 to 1.5. Days the market did not trade hold the previous close, flat.
- Market cap
- 15.6M USD
- Revenue, year to Dec 2025
- 2.8B USD
- EPS, diluted, year to Dec 2025
- −14.31 USD
- Avg volume
- 73.0K
- Mentions, 30 days
- 18
- Net sentiment
- +0.03
as of Nov 6, 2026
Have Accendra Health Inc/va/ (ACH) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, no Accendra Health Inc/va/ insider bought or sold shares on the open market; all 2 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 9 Nov 2026, newest Form 4 filing 5 Oct 2026
Buys 0Sells 0Other filings 2
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 05 Oct 2026 | Gardner-Smith KennethPresident & CEO | Award | 283,554 | |
| 23 Sep 2026 | Leon Jonathan AEVP & CFO | Tax withheld | 4,265 | 4K USD |
Which funds hold Accendra Health Inc/va/ (ACH)?
9 of the 45 institutional funds we track reported a Accendra Health Inc/va/ position for the quarter ended 30 Jun 2026 — a combined 31.0M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| D. E. Shaw & Co. | Held (±25%) | 3,081,407 | 10.5M USD | −7.0% |
| Marshall Wace | Added | 2,582,579 | 8.8M USD | +46.7% |
| AQR Capital Management | Added | 1,067,324 | 3.7M USD | +45.8% |
| Two Sigma Investments | Trimmed | 718,550 | 2.5M USD | −40.2% |
| Tudor Investment Corp | Added | 567,250 | 1.9M USD | +163.2% |
| Citadel Advisors | Added | 386,526 | 1.3M USD | +64.4% |
| Renaissance Technologies | Held (±25%) | 324,413 | 1.1M USD | +2.0% |
| Millennium Management | Trimmed | 202,018 | 691K USD | −57.5% |
| Man Group | New position | 127,488 | 436K USD | |
| Point72 Asset Management | Exited |
What has been filed or recorded for Accendra Health Inc/va/ (ACH)?
The filings we hold for Accendra Health Inc/va/, newest first: 8 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 110 shares | 43 USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 581 shares | 256 USD notional · 0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 13,176 shares | 6K USD notional · 0.017% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 99,839 shares | 51K USD notional · 0.130% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 78 shares | 48 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.25 USD | Revenue $602M |
| 30 Sep 2026 | Financials | Total assets | 2.1B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | −568.2M USD | at period end |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 547 shares | 388 USD notional · 0.001% of shares out |
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 70 shares | 51 USD notional · <0.001% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 6,014 shares | 5K USD notional · 0.008% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −1.16 USD | Revenue $613M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.08 USD | Revenue $628M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −14.31 USD | Revenue $2.76B |
| 31 Dec 2025 | Financials | Revenue | 2.8B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −1.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −14.31 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −1.94 USD | Revenue $697M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −11.30 USD | Revenue $682M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.32 USD | Revenue $674M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −4.73 USD | Revenue $2.68B |
What is Reddit saying about Accendra Health Inc/va/ (ACH)?
Reddit mentioned ACH 18 times in the 30 days to 8 November 2026, across 5 of the communities we track. All of them were scored for sentiment: 39% read bullish, 17% bearish and 44% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 18Bullish 39%Bearish 17%Communities 5Against the market −15 points
How do Reddit mentions of Accendra Health Inc/va/ (ACH) compare with its price?
Share ↗
Where Accendra Health Inc/va/ (ACH) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 44% | 8 | +0.01 |
| r/investing | 33% | 6 | +0.04 |
| r/cryptocurrency | 11% | 2 | +0.10 |
| r/etfs | 6% | 1 | −0.05 |
| r/stocks | 6% | 1 | +0.07 |
Moves with Accendra Health Inc/va/ (ACH)
Tickers whose daily Reddit volume rose and fell with Accendra Health Inc/va/ (ACH)'s. Co-discussion, not price.
CORZ +0.64SER +0.63KOSPI +0.61SOUTH KOREA +0.59TSM +0.57CRWV +0.57
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
The threads carrying the mentions
30 days, shown as posted
| Thread | Community | Mentions | Latest |
|---|---|---|---|
| Submitting multiple ACATs at once? And with ACHs?by u/Creative-Question538 | r/investing | 3 | 3 weeks ago |
Live discussion on Reddit, shown as posted. Titles link to the original threads.
Accendra Health Inc/va/ (ACH): frequently asked questions
What did Accendra Health Inc/va/ shares close at?
Accendra Health Inc/va/ closed at 0.2031 USD on 6 Nov 2026, down 33.15% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Accendra Health Inc/va/’s market cap?
Accendra Health Inc/va/ is worth 15.6M USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Accendra Health Inc/va/’s revenue?
Accendra Health Inc/va/ reported revenue of 2.8B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Accendra Health Inc/va/ insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, no Accendra Health Inc/va/ insider bought or sold shares on the open market; all 2 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Accendra Health Inc/va/?
9 of the 45 funds we track reported a Accendra Health Inc/va/ position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Marshall Wace and AQR Capital Management. See Funds
When did Accendra Health Inc/va/ last report earnings?
Accendra Health Inc/va/ last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.25 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Accendra Health Inc/va/?
Accendra Health Inc/va/ was mentioned 2 times in the last 7 days across the finance subreddits we track, and 18 times over the trailing 30 days. Of the 18 mentions scored for sentiment, 39% read bullish and 17% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings